| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
12,712 |
3,935 |
$878K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,974 |
8,349 |
$755K |
| 81025 |
|
5,015 |
4,684 |
$732K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,751 |
3,553 |
$633K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,643 |
2,574 |
$600K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,087 |
16,608 |
$496K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,879 |
11,539 |
$477K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
10,198 |
3,471 |
$476K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,873 |
3,720 |
$446K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,955 |
3,981 |
$342K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,751 |
1,673 |
$319K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,663 |
2,619 |
$191K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,789 |
1,697 |
$187K |
| 81003 |
|
11,635 |
10,142 |
$164K |
| 36415 |
Collection of venous blood by venipuncture |
3,305 |
2,311 |
$146K |
| 71046 |
Radiologic examination, chest; 2 views |
2,686 |
2,515 |
$91K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,327 |
2,733 |
$90K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,882 |
1,735 |
$87K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,805 |
1,969 |
$86K |
| 71045 |
Radiologic examination, chest; single view |
4,977 |
4,431 |
$74K |
| 80320 |
|
253 |
242 |
$59K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,740 |
8,918 |
$57K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,755 |
2,484 |
$53K |
| 73630 |
|
655 |
604 |
$52K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,812 |
4,911 |
$36K |
| 87631 |
|
196 |
189 |
$33K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,055 |
3,592 |
$32K |
| 73560 |
|
500 |
468 |
$32K |
| 80053 |
Comprehensive metabolic panel |
12,721 |
9,976 |
$29K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,997 |
3,576 |
$27K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,615 |
1,029 |
$27K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,751 |
2,277 |
$23K |
| 73610 |
|
256 |
247 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
173 |
168 |
$21K |
| 0353U |
|
76 |
72 |
$17K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
899 |
869 |
$16K |
| 87634 |
|
50 |
49 |
$15K |
| 73110 |
|
90 |
87 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,497 |
1,379 |
$14K |
| 73130 |
|
97 |
95 |
$14K |
| 82248 |
|
854 |
490 |
$13K |
| A9270 |
Non-covered item or service |
3,660 |
2,537 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
106 |
106 |
$11K |
| 73030 |
|
110 |
102 |
$10K |
| 97162 |
|
311 |
287 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
546 |
512 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,564 |
3,241 |
$8K |
| 84702 |
|
152 |
133 |
$7K |
| 83735 |
|
13,264 |
9,979 |
$7K |
| 74018 |
|
133 |
121 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,339 |
2,722 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
462 |
443 |
$7K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
511 |
339 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,481 |
1,116 |
$6K |
| 92526 |
|
125 |
55 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,390 |
1,174 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,711 |
1,156 |
$6K |
| 97010 |
|
29 |
14 |
$6K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$6K |
| 85027 |
|
1,525 |
1,282 |
$6K |
| 90715 |
|
154 |
153 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
134 |
44 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,998 |
4,106 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
27 |
26 |
$3K |
| 84484 |
|
3,412 |
2,775 |
$2K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
12 |
12 |
$2K |
| 85610 |
|
584 |
483 |
$2K |
| 72100 |
|
65 |
64 |
$2K |
| 85379 |
|
321 |
303 |
$2K |
| 73070 |
|
15 |
13 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
146 |
145 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,240 |
3,088 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
364 |
179 |
$1K |
| 97166 |
|
33 |
32 |
$1K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,410 |
1,346 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$917.50 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
78 |
73 |
$867.11 |
| 97116 |
|
165 |
65 |
$767.21 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
485 |
216 |
$764.45 |
| G0378 |
Hospital observation service, per hour |
544 |
258 |
$761.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,582 |
1,102 |
$757.58 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,271 |
1,014 |
$757.58 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
157 |
117 |
$755.80 |
| 80061 |
Lipid panel |
28 |
27 |
$747.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,185 |
2,299 |
$519.93 |
| 76642 |
|
13 |
13 |
$518.61 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
211 |
162 |
$491.76 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
13 |
$488.93 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$266.02 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
826 |
725 |
$215.42 |
| 84443 |
Thyroid stimulating hormone (TSH) |
856 |
796 |
$199.82 |
| 87088 |
|
1,054 |
968 |
$72.56 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
462 |
443 |
$66.75 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
12 |
$31.68 |
| 83690 |
|
2,761 |
2,469 |
$20.39 |
| 82550 |
|
370 |
326 |
$13.67 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
693 |
628 |
$0.00 |
| 87040 |
|
312 |
230 |
$0.00 |
| 85730 |
|
46 |
37 |
$0.00 |
| 83880 |
|
750 |
628 |
$0.00 |
| 86140 |
|
158 |
138 |
$0.00 |
| 96376 |
|
444 |
292 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
18 |
15 |
$0.00 |
| J3490 |
Unclassified drugs |
98 |
75 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
48 |
42 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
12 |
12 |
$0.00 |
| 83605 |
|
506 |
445 |
$0.00 |
| 80329 |
|
17 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
12 |
12 |
$0.00 |
| 94760 |
|
40 |
14 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
12 |
12 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
88 |
59 |
$0.00 |
| 82553 |
|
14 |
12 |
$0.00 |
| 85652 |
|
16 |
13 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
70 |
51 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
13 |
13 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,853 |
1,527 |
$0.00 |
| 87210 |
|
84 |
82 |
$0.00 |
| 87186 |
|
1,431 |
1,275 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
90 |
67 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
59 |
55 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
13 |
12 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
13 |
$0.00 |